Since IL-13 is involved in CRC progression and metastasis development by affecting epithelial to mesenchymal transition (EMT)39, we hypothesized that ILC2-derived IL-13 could affect EMT in CRC cells. This evidence concerns the gene IL13 and colorectal carcinoma.